Skip to main content
. 2013 Jan 23;3:1110. doi: 10.1038/srep01110

Table 5. Annotated metabolites, which differ between healthy subjects and UC patients in relapse (lumen).

Enriched in UC relapse          
No. Metabolite candidate MPCA (Da)/RT (min) MLCMS (Da) MHMDB (Da) Error (mDa) P values
11 Secondary bile acids 391.5/4 391.285527 391.285400 0.127 P<0.01
12 Salicyluric acid (drug) 194.5/2 194.046042 194.045993 0.110 P<0.001
13 Aminosalicylic acid (drug metabolite) or 3-Hydroxyanthranilic acid (oxidation product of tryptophan metabolism) 152.5/1 152.035358 152.035309 0.052 P<0.05
14 Product of phenylalanine metabolism 149.5/3 149.060764 149.060806 0.122 P<0.001
Enriched in healthy subjects          
No. Metabolite candidate MPCA (Da) MLCMS (Da) MHMDB (Da) Error (mDa) P values
15 Tryptophan 203.5/2 203.082491 203.082596 0.278 P<0.001
16 Phenyllactic acid or 4-methoxyphenylacetic acid or desaminotyrosine 165.5/3 165.055687 165.055710 0.023 P<0.05
17 Phenylglycine 150.5/2 150.056153 150.056046 0.107 P<0.001

Numbers from 11–17 correspond to the metabolite marked in the loading plot Figure 4. MPCA designates mass taken from PCA; RT designates retention time bucket of the PCA; MLCMS designates mass taken from LCMS analysis of test samples; MHMDB designates mass given by Human Metabolome Data Base; ‘Error’ designates the mass difference between measured MLCMS and found MHMDB.